-
1.
公开(公告)号:EP1948693A1
公开(公告)日:2008-07-30
申请号:EP06818817.6
申请日:2006-11-24
申请人: Ganymed Pharmaceuticals AG , Johannes Gutenberg-Universität Mainz, vertreten durch den Präsidenten
发明人: SAHIN, Ugur , TÜRECI, Özlem , USENER, Dirk , FRITZ, Stefan , UHEREK, Cristoph , BRANDENBURG, Gunda , GEPPERT, Harald-Gerhard , SCHRÖDER, Anja Kristina , THIEL, Philippe
IPC分类号: C07K16/30 , A61K39/395 , A61P35/00 , C12N5/12 , A61K47/48
CPC分类号: C07K16/18 , A61K39/3955 , A61K45/06 , A61K47/6803 , A61K47/6807 , A61K47/6809 , A61K47/6813 , A61K47/6821 , A61K47/6823 , A61K47/6829 , A61K47/6851 , A61K47/6859 , A61K47/6863 , A61K47/6869 , A61K51/1063 , A61K2039/505 , C07K16/28 , C07K16/3046 , C07K2317/14 , C07K2317/24 , C07K2317/51 , C07K2317/515 , C07K2317/56 , C07K2317/565 , C07K2317/73 , C07K2317/732 , C07K2317/734 , C07K2317/76
摘要: The present invention provides antibodies useful as therapeutics for treating and/or preventing diseases associated with cells expressing CLD18, including tumor-related diseases such as gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, hepatic cancer, head-neck cancer, and cancer of the gallbladder.
-
2.
公开(公告)号:EP1948693B1
公开(公告)日:2013-03-20
申请号:EP06818817.6
申请日:2006-11-24
申请人: Ganymed Pharmaceuticals AG , Johannes Gutenberg-Universität Mainz, vertreten durch den Präsidenten
发明人: SAHIN, Ugur , TÜRECI, Özlem , USENER, Dirk , FRITZ, Stefan , UHEREK, Christoph , BRANDENBURG, Gunda , GEPPERT, Harald-Gerhard , SCHRÖDER, Anja Kristina , THIEL, Philippe
CPC分类号: C07K16/18 , A61K39/3955 , A61K45/06 , A61K47/6803 , A61K47/6807 , A61K47/6809 , A61K47/6813 , A61K47/6821 , A61K47/6823 , A61K47/6829 , A61K47/6851 , A61K47/6859 , A61K47/6863 , A61K47/6869 , A61K51/1063 , A61K2039/505 , C07K16/28 , C07K16/3046 , C07K2317/14 , C07K2317/24 , C07K2317/51 , C07K2317/515 , C07K2317/56 , C07K2317/565 , C07K2317/73 , C07K2317/732 , C07K2317/734 , C07K2317/76
摘要: The present invention provides antibodies useful as therapeutics for treating and/or preventing diseases associated with cells expressing CLD18, including tumor-related diseases such as gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, hepatic cancer, head-neck cancer, and cancer of the gallbladder.
-
公开(公告)号:EP1749027B1
公开(公告)日:2016-08-10
申请号:EP05745559.4
申请日:2005-05-18
IPC分类号: C07K14/47 , C07K16/30 , A61K39/395 , A61P35/00
CPC分类号: A61K6/00 , A61K47/6851 , A61K49/00 , A61K2039/505 , C07K14/47 , C07K14/705 , C07K16/18 , C07K16/28 , C07K16/30 , C07K16/303 , C07K16/3046 , C07K16/3076 , C07K16/44 , C07K2317/24 , C07K2317/34 , C07K2317/73 , C07K2317/75 , C12N9/88 , C12Y406/01002 , G01N33/57496
-
-